A giant sculpture inspired by the sun is to go on display at National Trust locations this year. Helios, named after the ancient Greek mythological god who personified the sun, is by acclaimed artist ...
Recently, an 80-year-old man in Ahmedabad tested positive for human metapneumovirus (hMPV), adding to the growing cases of ...
Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
Seasoned biotechnology industry leadership spanning three decades across U.S. and global commercial operations ...
NEW YORK, NY / ACCESSWIRE / January 10, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a ...
U.S.-based biotech builder Mountainfield Venture Partners and China’s Keymed Biosciences have launched a new company armed ...
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...
Alzheimer’s could be diagnosed 10 years earlier after world’s largest blood proteins study - UK based project could pave way ...
A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...
Daiichi Sankyo's stock dropped 25% due to disappointing clinical data, but upcoming studies could drive a rebound for ...
New treatments like dotinurad provide safer, more effective solutions for millions battling gout and hyperuricemia.
10h
If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback